{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:17:23Z","timestamp":1790248643889,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacc.2026.04.044","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:32:35Z","timestamp":1780497155000},"page":"652-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-2593","authenticated-orcid":false,"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Linetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Ruotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-8533","authenticated-orcid":false,"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Sourij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9481-1984","authenticated-orcid":false,"given":"Kadie","family":"Vanderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Stefanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1249-4522","authenticated-orcid":false,"given":"Paul M","family":"Ridker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2026.04.044_bib1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(11)60105-0","article-title":"Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies","volume":"377","author":"Wormser","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.04.044_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/cvr\/cvx086","article-title":"New insights into the role of adipose tissue in thrombosis","volume":"113","author":"Vilahur","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2026.04.044_bib3","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc23-0855","article-title":"Genetic evidence strongly supports managing weight and blood pressure in addition to glycemic control in preventing vascular complications in people with type 2 diabetes","volume":"46","author":"Ahmed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2026.04.044_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","article-title":"Understanding the mechanisms of reversal of type 2 diabetes","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2026.04.044_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","article-title":"Obesity, kidney dysfunction and hypertension: mechanistic links","volume":"15","author":"Hall","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2026.04.044_bib6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2026.04.044_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.04.044_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/dom.14553","article-title":"The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: a post hoc analysis","volume":"24","author":"Wilson","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2026.04.044_bib9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.04.044_bib10","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.04.044_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/dom.15318","article-title":"Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis","volume":"26","author":"Hankosky","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2026.04.044_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.04.044_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple hypothesis testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.jacc.2026.04.044_bib14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2026.04.044_bib15","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa049","article-title":"Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects","volume":"4","author":"Biobaku","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jacc.2026.04.044_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101737","article-title":"Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials","volume":"55","author":"Verma","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacc.2026.04.044_bib17","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.04.044_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.04.044_bib19","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1056\/NEJMoa2505928","article-title":"Cardiovascular outcomes with tirzepatide versus dulaglutide in type 2 diabetes","volume":"393","author":"Nicholls","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.04.044_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.119.045256","article-title":"From CANTOS to CIRT to COLCOT to clinic: will all atherosclerosis patients soon be treated with combination lipid-lowering and inflammation-inhibiting agents?","volume":"141","author":"Ridker","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.04.044_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13910","article-title":"The effect of dietary weight-loss interventions on the inflammatory markers interleukin-6 and TNF-alpha in adults with obesity: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"26","author":"Bulmer","year":"2025","journal-title":"Obes Rev"},{"key":"10.1016\/j.jacc.2026.04.044_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/ejh.13560","article-title":"The hematologic consequences of obesity","volume":"106","author":"Purdy","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jacc.2026.04.044_bib23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/antiox9080734","article-title":"Effect of Roux-en-Y bariatric bypass surgery on subclinical atherosclerosis and oxidative stress markers in leukocytes of obese patients: a one-year follow-up study","volume":"9","author":"Abad-Jim\u00e9nez","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jacc.2026.04.044_bib24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"IL6R Genetics Consortium Emerging Risk Factors Collaboration","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.04.044_bib25","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.04.044_bib26","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2026.04.044_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s43556-024-00214-x","article-title":"Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation","volume":"5","author":"Nencini","year":"2024","journal-title":"Mol Biomed"},{"key":"10.1016\/j.jacc.2026.04.044_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s11010-024-05066-1","article-title":"Tirzepatide alleviates oxidative stress and inflammation in diabetic nephropathy via IL-17 signaling pathway","volume":"480","author":"Yang","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacc.2026.04.044_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15462","article-title":"Clinical utility of liver function tests for resolution of metabolic dysfunction-associated steatotic liver disease after weight loss in the Diabetes Remission Clinical Trial","volume":"42","author":"Zhyzhneuskaya","year":"2025","journal-title":"Diabet Med"},{"key":"10.1016\/j.jacc.2026.04.044_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101435","article-title":"Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: a prospective cohort study in the UK Biobank","volume":"48","author":"Ho","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacc.2026.04.044_bib31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s00125-008-0954-7","article-title":"Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?","volume":"51","author":"Sattar","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2026.04.044_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cmet.2018.07.003","article-title":"Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for \u03b2 cell recovery","volume":"28","author":"Taylor","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacc.2026.04.044_bib33","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s11695-023-06702-3","article-title":"3-Month post-operative increase in FGF21 is predictive of one-year weight loss after bariatric surgery","volume":"33","author":"De Luca","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2026.04.044_bib34","article-title":"Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids","volume":"5","author":"Fiorenza","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jacc.2026.04.044_bib35","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2026.04.044_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","article-title":"Metabolic messengers: FGF21","volume":"3","author":"Flippo","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.jacc.2026.04.044_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.04.044_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00125-008-1217-3","article-title":"Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly","volume":"52","author":"Sattar","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2026.04.044_bib39","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1007\/s11695-020-04710-1","article-title":"Effect of surgically induced weight loss on biomarkers of endothelial dysfunction: a systematic review and meta-analysis","volume":"30","author":"Seyyedi","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2026.04.044_bib40","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s11695-014-1484-7","article-title":"Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity","volume":"25","author":"Netto","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2026.04.044_bib41","article-title":"E-selectin in vascular pathophysiology","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacc.2026.04.044_bib42","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1177\/0300060517706578","article-title":"Cardiovascular risk of adipokines: a review","volume":"46","author":"Dutheil","year":"2018","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jacc.2026.04.044_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1055\/s-0031-1297369","article-title":"Obesity and venous thrombosis: a review","volume":"37","author":"Allman-Farinelli","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2026.04.044_bib45","first-page":"4348","article-title":"Interacting hepatic PAI-1\/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity","volume":"130","author":"Zheng","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2026.04.044_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11695-016-2292-z","article-title":"Effect of bariatric surgery-induced weight loss on platelet count and mean platelet volume: a 12-month follow-up study","volume":"27","author":"Raoux","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2026.04.044_bib47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00011-012-0473-3","article-title":"Inflammatory markers and bariatric surgery: a meta-analysis","volume":"61","author":"Rao","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jacc.2026.04.044_bib48","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2337\/dc25-0763","article-title":"Tirzepatide treatment and associated changes in \u03b2-cell function and insulin sensitivity in people with obesity or overweight with prediabetes or normoglycemia: a post hoc analysis from the SURMOUNT-1 trial","volume":"48","author":"Mari","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2026.04.044_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1603670","article-title":"Effect of bariatric surgery on glycemic and metabolic outcomes in people with obesity and type 2 diabetes mellitus: a systematic review, meta-analysis, and meta-evidence of 39 studies","volume":"12","author":"Wei","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.jacc.2026.04.044_bib50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-0040-1702224","article-title":"Effects of obesity surgery on blood coagulation and fibrinolysis: a literature review","volume":"120","author":"Bladbjerg","year":"2020","journal-title":"Thromb Haemost"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726064168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726064168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:48:29Z","timestamp":1786463309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109726064168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0735109726064168"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.04.044","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}